NIH Weekly Funding Opportunities and Policy Notices
Funding Opportunity PAR-22-119 from the NIH Guide for Grants and Contracts. Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03)
Funding Opportunity PAR-22-128 from the NIH Guide for Grants and Contracts. The National Eye Institute (NEI) supports large-scale clinical vision research projects, including randomized clinical trials and epidemiologic studies. At the time of submission, applications requesting support for these activities are expected to provide detailed information regarding the study rationale, design, analytic techniques, protocols and procedures, facilities and environment, organizational structure, and collaborative arrangements. This information is best conveyed in a well-documented Manual of Procedures (MOP), the development of which represents a costly and time-consuming activity. This FOA is designed to facilitate activities central to the refinement of a study protocol and procedures and the development of a detailed MOP. The NEI Clinical Study Planning Grant may be used to support the development of a MOP, as well as to conduct preliminary studies to refine study procedures or document recruitment potential. The grant must not be used to generate data on the effects of a proposed intervention. This NEI FOA is applicable to both epidemiologic and clinical trial research studies.
Notice NOT-TR-22-016 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DE-23-010 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is soliciting applications to support the planning and implementation of research to establish effective interventions or programs to manage, reduce, or prevent opioid drug misuse and align the opioid prescribing practices of dental professionals with scientific evidence.
Notice NOT-AI-22-030 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-NS-22-028 from the NIH Guide for Grants and Contracts. Reissue of:RFA-NS-18-029 and RFA-NS-20-029. This funding opportunity announcement (FOA) is designed to support teams of investigators that seek to cross boundaries of interdisciplinary collaboration to elucidate the contributions of dynamic circuit activity to a specific behavioral or neural system. Applications are encouraged to propose adventurous and challenging goals that can only be tackled by a synergistic team-based approach and have the potential to be transformative and/or to enable significant advances. These studies at the exploratory stage are intended for the development of experimental capabilities and/or theoretical frameworks in preparation for a future competition for larger-scale or extended efforts, including the BRAIN TargetedBCP R01 or the multi-component, Team-Research BRAIN Circuit Programs (U19).The overall goal of this FOA is to enable a large-scale analysis of neural systems and circuits within the context and during the simultaneous measurement of an ethologically relevant behavior. Toward this end, teams are expected to assemble and leverage multi-disciplinary expertise, and to integrate experimental with computational and theoretical approaches. Teams are expected to bridge fields by incorporating rich information on cell-types, on circuit functionality and connectivity, in conjunction with sophisticated analyses of an ethologically relevant behavior of an organism or a well-defined neural system. Teams are also expected to aim for a mechanistic understanding of the circuits of the central nervous system (CNS) by applying cutting-edge methods such as those for large-scale recording, manipulation, and analysis of neural circuits across multiple regions of the CNS.
Notice NOT-OD-22-080 from the NIH Guide for Grants and Contracts
Notice NOT-DA-23-006 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-22-122 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for Clinical and Translational Science Awards (CTSA) Program consortium-wide resource centers that will rapidly demonstrate and disseminate to the wider consortium innovative resources (to include capabilities) that have established impact at a local or national level. Applications for CTSA consortium-wide centers are expected to rapidly demonstrate and disseminate resources to advance clinical and translational science efforts.Only applications submitted in response to a Notice of Special Interest (NOSI) published by NCATS will be allowed to apply to this FOA.
Notice NOT-MH-22-180 from the NIH Guide for Grants and Contracts
Notice NOT-TR-22-019 from the NIH Guide for Grants and Contracts
Notice NOT-CA-22-059 from the NIH Guide for Grants and Contracts
Notice NOT-GM-22-016 from the NIH Guide for Grants and Contracts
Notice NOT-NS-22-085 from the NIH Guide for Grants and Contracts
Notice NOT-CA-22-058 from the NIH Guide for Grants and Contracts
Notice NOT-RM-22-007 from the NIH Guide for Grants and Contracts
Notice NOT-RM-22-008 from the NIH Guide for Grants and Contracts
Notice NOT-RM-22-009 from the NIH Guide for Grants and Contracts
Notice NOT-RM-22-006 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AG-23-011 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to stimulate research in noncoding ribonucleic acids (ncRNAs) to investigate the causality, directionality, mechanisms, and therapeutic potential of ncRNAs implicated in Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD). This FOA will support exploratory and developmental Grant (R21) applications seeking to discover functional roles of ncRNAs and underlying mechanisms involved in the pathogenesis and progression of AD/ADRD. Proposed studies should focus on functional characterization and mechanistic investigation of previously identified ncRNAs.